title: Risk profiling patients for selective use of drug-eluting stents is warranted.
authors.affiliation: Mount Sinai Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029 USA. michael.farkouh@mssm.edu
authors.forename: Michael E
authors.initials: ME
authors.lastname: Farkouh
authors.forename: Sameer
authors.initials: S
authors.lastname: Bansilal
authors.forename: Valentin
authors.initials: V
authors.lastname: Fuster
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D023903:Coronary Restenosis / Q000209:etiology*; D016503:Drug Delivery Systems; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology; D018570:Risk Assessment; D015607:Stents / Q000009:adverse effects*